147 related articles for article (PubMed ID: 8336195)
21. Activity of doxorubicin and cisplatin combination chemotherapy in patients with diffuse malignant pleural mesothelioma. An Italian Lung Cancer Task Force (FONICAP) Phase II study.
Ardizzoni A; Rosso R; Salvati F; Fusco V; Cinquegrana A; De Palma M; Serrano J; Pennucci MC; Soresi E; Crippa M
Cancer; 1991 Jun; 67(12):2984-7. PubMed ID: 2044044
[TBL] [Abstract][Full Text] [Related]
22. Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study.
Samson MK; Wasser LP; Borden EC; Wanebo HJ; Creech RH; Phillips M; Baker LH
J Clin Oncol; 1987 Jan; 5(1):86-91. PubMed ID: 3543239
[TBL] [Abstract][Full Text] [Related]
23. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.
Rusch VW; Niedzwiecki D; Tao Y; Menendez-Botet C; Dnistrian A; Kelsen D; Saltz L; Markman M
J Clin Oncol; 1992 Jun; 10(6):1001-6. PubMed ID: 1588364
[TBL] [Abstract][Full Text] [Related]
24. Treatment of six cases of mesothelioma with doxorubicin and cisplatin.
Zidar BL; Pugh RP; Schiffer LM; Raju RN; Vaidya KA; Bloom RL; Horne D; Baker LH
Cancer; 1983 Nov; 52(10):1788-91. PubMed ID: 6684983
[TBL] [Abstract][Full Text] [Related]
25. A case report of malignant pleural mesothelioma with long-term disease control after chemotherapy.
Umsawasdi T; Dhingra HM; Charnsangavej C; Luna MA
Cancer; 1991 Jan; 67(1):48-54. PubMed ID: 1898706
[TBL] [Abstract][Full Text] [Related]
26. Patterns of failure following surgical resection for malignant pleural mesothelioma.
Jänne PA; Baldini EH
Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
[TBL] [Abstract][Full Text] [Related]
27. Phase-II study with the combination of cisplatin and doxorubicin in advanced malignant mesothelioma of the pleura.
Henss H; Fiebig HH; Schildge J; Arnold H; Hasse J
Onkologie; 1988 Jun; 11(3):118-20. PubMed ID: 3045724
[TBL] [Abstract][Full Text] [Related]
28. Combined chemotherapy in pleurectomized malignant pleural mesothelioma patients.
Hastürk S; Tastepe I; Unlü M; Cetin G; Baris YI
J Chemother; 1996 Apr; 8(2):159-64. PubMed ID: 8708749
[TBL] [Abstract][Full Text] [Related]
29. Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807).
Otterson GA; Herndon JE; Watson D; Green MR; Kindler HL;
Lung Cancer; 2004 May; 44(2):251-9. PubMed ID: 15084390
[TBL] [Abstract][Full Text] [Related]
30. Phase II trial of high-dose cisplatin in patients with malignant mesothelioma.
Mintzer DM; Kelsen D; Frimmer D; Heelan R; Gralla R
Cancer Treat Rep; 1985 Jun; 69(6):711-2. PubMed ID: 4040424
[TBL] [Abstract][Full Text] [Related]
31. Cisplatin in combination with irinotecan in the treatment of patients with malignant pleural mesothelioma: a pilot phase II clinical trial and pharmacokinetic profile.
Nakano T; Chahinian AP; Shinjo M; Togawa N; Tonomura A; Miyake M; Ninomiya K; Yamamoto T; Higashino K
Cancer; 1999 Jun; 85(11):2375-84. PubMed ID: 10357408
[TBL] [Abstract][Full Text] [Related]
32. The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma. A phase II randomized trial of the Italian Oncology Group for Clinical Research.
De Lisi V; Cocconi G; Angelini F; Cavicchi F; Di Costanzo F; Gilli G; Rodinò C; Soldani M; Tonato M; Finardi C
Cancer; 1996 Jan; 77(2):245-50. PubMed ID: 8625230
[TBL] [Abstract][Full Text] [Related]
33. [A diffuse, pleural, malignant mesothelioma kept in long remission by chemotherapy combining pirarubicin and cisplatin].
Niki Y; Soga T; Nishimura A; Kato M; Hamada M; Kanamaru M
Gan No Rinsho; 1990 Nov; 36(14):2463-7. PubMed ID: 2250368
[TBL] [Abstract][Full Text] [Related]
34. Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.
Govindan R; Kratzke RA; Herndon JE; Niehans GA; Vollmer R; Watson D; Green MR; Kindler HL;
Clin Cancer Res; 2005 Mar; 11(6):2300-4. PubMed ID: 15788680
[TBL] [Abstract][Full Text] [Related]
35. The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant mesothelioma.
Andreopoulou E; Ross PJ; O'Brien ME; Ford HE; Priest K; Eisen T; Norton A; Ashley S; Smith IE
Ann Oncol; 2004 Sep; 15(9):1406-12. PubMed ID: 15319247
[TBL] [Abstract][Full Text] [Related]
36. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Cabras AD; Bertulli R; Hutanu I; Deraco M
Eur J Cancer; 2013 Oct; 49(15):3140-8. PubMed ID: 23831335
[TBL] [Abstract][Full Text] [Related]
37. Cisplatin, mitomycin, and interferon-alpha2a combination chemoimmunotherapy in the treatment of diffuse malignant pleural mesothelioma.
Metintas M; Ozdemir N; Uçgun I; Elbek O; Kolsuz M; Mutlu S; Metintas S
Chest; 1999 Aug; 116(2):391-8. PubMed ID: 10453867
[TBL] [Abstract][Full Text] [Related]
38. A phase II study of VP-16 and cisplatin in patients with unresectable malignant mesothelioma. An NCI Canada Clinical Trials Group Study.
Eisenhauer EA; Evans WK; Murray N; Kocha W; Wierzbicki R; Wilson K
Invest New Drugs; 1988 Dec; 6(4):327-9. PubMed ID: 3229945
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma.
Markman M; Kelsen D
J Cancer Res Clin Oncol; 1992; 118(7):547-50. PubMed ID: 1624547
[TBL] [Abstract][Full Text] [Related]
40. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.
Deraco M; Casali P; Inglese MG; Baratti D; Pennacchioli E; Bertulli R; Kusamura S
J Surg Oncol; 2003 Jul; 83(3):147-53. PubMed ID: 12827682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
